Stroke patients treated by thrombectomy in real life differ from cohorts of the clinical trials: a prospective observational study.
Basilar artery occlusion
Clinical practice
Reperfusion
Stroke
Thrombectomy
Journal
BMC neurology
ISSN: 1471-2377
Titre abrégé: BMC Neurol
Pays: England
ID NLM: 100968555
Informations de publication
Date de publication:
05 Mar 2020
05 Mar 2020
Historique:
received:
24
02
2019
accepted:
24
02
2020
entrez:
7
3
2020
pubmed:
7
3
2020
medline:
31
7
2020
Statut:
epublish
Résumé
Randomized controlled trials (RCTs) demonstrated efficacy and safety of endovascular treatment (ET) in anterior circulation large vessel occlusions (LVO). We aimed at investigating how stroke patients treated by thrombectomy in clinical practice and their outcome compare to cohorts and results of thrombectomy trials. In a prospective study, we consecutively included stroke patients treated by thrombectomy (2015-2017). Baseline characteristics, procedural and outcome data were analyzed. Outcome was assessed by modified Rankin Scale (mRS) at 90 days. Ordinal regression analysis was performed to identify predictors of outcome. Thrombectomy was applied in 264 patients (median 75 years, 49.6% female). Median baseline National Institutes of Health Stroke Scale (NIHSS) was 16, 58.0% received concomitant intravenous thrombolysis, 62.1% were referred from external hospitals. Median Alberta Stroke Program Early CT Score (ASPECTS) was 7. Successful recanalization (modified Thrombolysis in Cerebral Infarction Score, mTICI 2b/3) was achieved in 72.0%. Symptomatic intracranial hemorrhage (sICH) occurred in 4.5%. Independent outcome (mRS 0-2) was achieved in 26.2%, poor outcome (mRS 5-6) in 49.2%. Only 33.5% met the stringent enrolment criteria of previous RCTs. Lower age, baseline NIHSS, pre-stroke mRS, higher ASPECTS, and successful recanalization were independent predictors of favourable outcome. The majority of stroke patients treated by ET in clinical practice would not have qualified for randomization in prior RCTs. Outcome in real-life patient cohorts is worse than in the highly selected cohorts from randomized trials, while rates of successful recanalization, sICH and outcome predictors are the same. Our findings support ET in broader patient populations than in the RCTs and may improve treatment decision in individual stroke patients with LVO in clinical practice.
Sections du résumé
BACKGROUND
BACKGROUND
Randomized controlled trials (RCTs) demonstrated efficacy and safety of endovascular treatment (ET) in anterior circulation large vessel occlusions (LVO). We aimed at investigating how stroke patients treated by thrombectomy in clinical practice and their outcome compare to cohorts and results of thrombectomy trials.
METHODS
METHODS
In a prospective study, we consecutively included stroke patients treated by thrombectomy (2015-2017). Baseline characteristics, procedural and outcome data were analyzed. Outcome was assessed by modified Rankin Scale (mRS) at 90 days. Ordinal regression analysis was performed to identify predictors of outcome.
RESULTS
RESULTS
Thrombectomy was applied in 264 patients (median 75 years, 49.6% female). Median baseline National Institutes of Health Stroke Scale (NIHSS) was 16, 58.0% received concomitant intravenous thrombolysis, 62.1% were referred from external hospitals. Median Alberta Stroke Program Early CT Score (ASPECTS) was 7. Successful recanalization (modified Thrombolysis in Cerebral Infarction Score, mTICI 2b/3) was achieved in 72.0%. Symptomatic intracranial hemorrhage (sICH) occurred in 4.5%. Independent outcome (mRS 0-2) was achieved in 26.2%, poor outcome (mRS 5-6) in 49.2%. Only 33.5% met the stringent enrolment criteria of previous RCTs. Lower age, baseline NIHSS, pre-stroke mRS, higher ASPECTS, and successful recanalization were independent predictors of favourable outcome.
CONCLUSIONS
CONCLUSIONS
The majority of stroke patients treated by ET in clinical practice would not have qualified for randomization in prior RCTs. Outcome in real-life patient cohorts is worse than in the highly selected cohorts from randomized trials, while rates of successful recanalization, sICH and outcome predictors are the same. Our findings support ET in broader patient populations than in the RCTs and may improve treatment decision in individual stroke patients with LVO in clinical practice.
Identifiants
pubmed: 32138684
doi: 10.1186/s12883-020-01653-z
pii: 10.1186/s12883-020-01653-z
pmc: PMC7059360
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
81Références
J Neuroradiol. 2018 Jul;45(4):211-216
pubmed: 29470997
N Engl J Med. 2015 Jun 11;372(24):2285-95
pubmed: 25882376
N Engl J Med. 2018 Feb 22;378(8):708-718
pubmed: 29364767
Lancet. 2007 Jan 27;369(9558):275-82
pubmed: 17258667
N Engl J Med. 2015 Jan 1;372(1):11-20
pubmed: 25517348
Neurol Neurochir Pol. 2017 Jan - Feb;51(1):12-18
pubmed: 27717502
J Neurointerv Surg. 2016 Nov;8(11):1107-1115
pubmed: 26610730
Lancet. 2016 Apr 23;387(10029):1723-31
pubmed: 26898852
World Neurosurg. 2017 Aug;104:1-8
pubmed: 28427984
N Engl J Med. 2015 Mar 12;372(11):1019-30
pubmed: 25671798
J Stroke Cerebrovasc Dis. 2017 Dec;26(12):2793-2799
pubmed: 28754235
ScientificWorldJournal. 2015;2015:403726
pubmed: 26137591
N Engl J Med. 2015 Mar 12;372(11):1009-18
pubmed: 25671797
J Korean Neurosurg Soc. 2017 Nov;60(6):635-643
pubmed: 29142622
Clin Neuroradiol. 2018 Sep;28(3):313-326
pubmed: 29744519
Neuroradiology. 2018 Feb;60(2):123-126
pubmed: 29275515
N Engl J Med. 2018 Jan 4;378(1):11-21
pubmed: 29129157
Stroke. 2015 Oct;46(10):3020-35
pubmed: 26123479
J Neurointerv Surg. 2018 Jun;10(6):516-524
pubmed: 28963367
N Engl J Med. 2015 Jun 11;372(24):2296-306
pubmed: 25882510